Is Keurig Dr Pepper (KDP) Stock Too Expensive After A 19% Gain?

Keurig Dr Pepper has delivered a solid 19.2% gain over the past year, yet its low value score and an overvalued read on market multiples suggest the current share price is not an obvious bargain.

• The 19.2% return over the past 12 months highlights that recent shareholders have been rewarded, which naturally raises the bar for any new upside case.
• The agreed sale of the Chobani stake and the Allentown facility for a combined US$925m can support debt reduction and flexibility. At the same time, the planned split into Beverage Co. and Global Coffee Co. adds execution risk around how earnings and balance sheet strength will be shared between the two future entities.
• A low value score of 2 out of 6 means Keurig Dr Pepper screens as leaning expensive on the wider cross checks rather than as a clear-cut value idea.

The issue now is whether Keurig Dr Pepper's recent share price strength and portfolio reshaping leave enough valuation headroom for investors buying at current levels.

Compare Keurig Dr Pepper's recent 19.2% one year return with other stocks that pair solid fundamentals with valuation support by scanning 31 high quality undervalued stocks.

Does Keurig Dr Pepper Look Pricey on Earnings?

P/E suits Keurig Dr Pepper because earnings remain a key anchor for how investors assess mature beverage groups. On that yardstick, the stock trades at about 31.8x earnings, which is clearly above the Beverage industry average of roughly 16.7x and ahead of the peer group near 24.4x. The model’s tailored fair P/E, which attempts to reflect Keurig Dr Pepper’s margins, size and risk profile, sits closer to 25.4x.

The current P/E therefore carries a premium of roughly a quarter to that fair ratio. This suggests the market is already paying up for the story. Despite the recent Chobani stake and Allentown facility sale improving financial flexibility, the share price still implies a richer earnings multiple than both the industry and the model-based benchmark.

On this P/E yardstick, Keurig Dr Pepper screens as overvalued, with the valuation already baking in a generous earnings outlook.

See what the numbers say about this price — find out in our valuation breakdown.

The Keurig Dr Pepper Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Keurig Dr Pepper pick up where that valuation puzzle leaves off, by spelling out which paths for future growth, margins and earnings would need to play out for the stock to be worth meaningfully more or less than today’s price, and they sit on the company’s Community page. Rather than stopping at a single model outcome, these scenarios unpack the assumptions underneath it so you can watch how Keurig Dr Pepper's real world performance lines up over time.

Use Simply Wall St Narratives to add your own take on whether Keurig Dr Pepper's US$925m Chobani stake and Allentown facility sale, as well as the planned split into Beverage Co. and Global Coffee Co., really supports the value implied by today’s share price. Share a number-driven view now so you can track how it stacks up against Keurig Dr Pepper's actual results over time.

Do you think there's more to the story for Keurig Dr Pepper? Head over to our Community to see what others are saying!

The Bottom Line

Keurig Dr Pepper screens as overvalued on P/E, with the current multiple already leaning well ahead of both sector peers and the tailored fair ratio. That kind of premium leaves less room for error and leans heavily on the market staying comfortable with elevated expectations around earnings quality and stability. The crux for investors is whether that rich rating holds as the business reshapes around the beverage and coffee split, or whether sentiment cools and the multiple does the heavy lifting on any future downside or upside.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com